Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study.

Saved in:
Bibliographic Details
Title: Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study.
Authors: Hosseini-Ashrafi M; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Clayton TH; Department of Paediatric Dermatology, Royal Manchester Children's Hospital, Manchester, UK., Herring M; Department of Paediatric Allergy & Immunology, Royal Manchester Children's Hospital, Manchester, UK., Herety N; Department of Paediatric Dermatology, Royal Manchester Children's Hospital, Manchester, UK., Arkwright PD; Department of Paediatric Allergy & Immunology, Royal Manchester Children's Hospital, Manchester, UK.; The Lydia Becker Institute of Immunology and Inflammation, The University of Manchester, Manchester, UK.
Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2024 May 21; Vol. 49 (6), pp. 578-583.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2230
DOI:10.1093/ced/llae013